Published in Lab Business Week, September 26th, 2004
Investors also will receive warrants to purchase approximately 1.6 million shares of common stock at an exercise price of $3.50 per share. Leerink Swann & Company served as placement agent for the transaction.
This transaction is expected to be consummated within the next few days following satisfaction of certain customary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.